Reliable change in neuropsychological assessment of breast cancer survivors

被引:32
作者
Andreotti, Charissa [1 ]
Root, James C. [1 ]
Schagen, Sanne B. [2 ]
McDonald, Brenna C. [3 ]
Saykin, Andrew J. [3 ]
Atkinson, Thomas M. [1 ]
Li, Yuelin [1 ]
Ahles, Tim A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, 641 Lexington Ave,7th Floor, New York, NY 10022 USA
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[3] Indiana Univ Sch Med, Indiana Univ Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA
关键词
neuropsychological assessment; cognition; breast cancer; survivorship; COGNITIVE CHANGE; DEMENTIA; STATE; AGE;
D O I
10.1002/pon.3799
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe purpose of this study was to enhance the current understanding and interpretation of longitudinal change on tests of neurocognitive function in individuals with cancer. Scores on standard neuropsychological instruments may be impacted by practice effects and other random forms of error. MethodsThe current study assessed the test-retest reliability of several tests and overarching cognitive domains comprising a neurocognitive battery typical of those used for research and clinical evaluation using relevant time frames. Practice effect-adjusted reliable change confidence intervals for test-retest difference scores based on a sample of patient-matched healthy controls are provided. ResultsBy applying reliable change confidence intervals to scores from two samples of breast cancer patients at post-treatment follow-up assessment, meaningful levels of detectable change in cognitive functioning in breast cancer survivors were ascertained and indicate that standardized neuropsychological instruments may be subject to limitations in detection of subtle cognitive dysfunction over clinically relevant intervals, especially in patient samples with average to above average range baseline functioning. ConclusionsThese results are discussed in relation to reported prevalence of cognitive change in breast cancer patients along with recommendations for study designs that enhance detection of treatment effects. Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 25 条
  • [1] The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
    Ahles, TA
    Saykin, AJ
    Noll, WW
    Furstenberg, CT
    Guerin, S
    Cole, B
    Mott, LA
    [J]. PSYCHO-ONCOLOGY, 2003, 12 (06) : 612 - 619
  • [2] Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
    Ahles, Tim A.
    Root, James C.
    Ryan, Elizabeth L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30) : 3675 - 3686
  • [3] Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
    Ahles, Tim A.
    Saykin, Andrew J.
    McDonald, Brenna C.
    Li, Yuelin
    Furstenberg, Charlotte T.
    Hanscom, Brett S.
    Mulrooney, Tamsin J.
    Schwartz, Gary N.
    Kaufman, Peter A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4434 - 4440
  • [4] Aldenkamp AP., 1994, FEPSY IRON PSYCHE
  • [5] [Anonymous], 1978, De stroop kleur-woord test. handleiding
  • [6] Cohen J, 2013, Statistical power analysis for the behavioral sciences, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]
  • [7] Delis D.C., 2001, DELIS KAPLAN EXECUTI
  • [8] Delis JH, 2000, CALIFORNIA VERBAL LE
  • [9] Gordon M., 1986, GORDON DIAGNOSTIC SY
  • [10] Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination
    Hensel, A.
    Angermeyer, M. C.
    Riedel-Heller, S. G.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (12) : 1298 - 1303